Stridex Essential by Blistex Inc / Accupac LLC

Stridex Essential by

Drug Labeling and Warnings

Stridex Essential by is a Otc medication manufactured, distributed, or labeled by Blistex Inc, Accupac LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

STRIDEX ESSENTIAL- salicylic acid liquid 
Blistex Inc

----------

Active ingredient

Salicylic Acid 1.0%(w/w)

Purpose

Acne medication

Uses

for the treatment of acne

reduces the number of acne pimples and blackheads and allows skin to heal

helps prevent new acne pimples from forming

Warnings

For external use only

Allergy alert:

do not use this product if you have a known allergy to salicylic acid

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Keep out of the reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

-clean the skin thoroughly before applying this product

-use the pad to cover the entire affected area with a thin layer one to three times daily

-because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed of as directed by a doctor

-if bothersome dryness or peeling occurs, reduce application to once a day or every other day

-do not use if seal is broken

-do not leave pad on skin for an extended period of tme

-keep away from eyes, lips and other mucous membranes

Other information

DO NOT FLUSH-discard pad in trash and wash hands after use

Inactive ingredients

Water

Ammonium Xylenesulfonate

Ammonium Lauryl Sulfate

Sodium Citrate

Phenoxyethanol

Ethylhexyglycerin

Sodium Hydroxide

Menthol

Silicon dioxide

Sodium Ascorbyl Phosphate

Edetate Sodium

Alpha-Tocopherol acetate

label

STRIDEX ESSENTIAL 
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 10157-2119
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	1 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
EDETATE SODIUM (UNII: MP1J8420LU)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
WATER (UNII: 059QF0KO0R)
AMMONIUM XYLENESULFONATE (UNII: 4FZY6L6XCM)
AMMONIUM LAURYL SULFATE (UNII: Q7AO2R1M0B)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
MENTHOL (UNII: L7T10EIP3A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM ASCORBYL PHOSPHATE (UNII: 836SJG51DR)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 10157-2119-2	1 in 1 CARTON	12/06/2022
1		55 in 1 JAR
1		2 mL in 1 APPLICATOR; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M004	12/06/2022	01/15/2026

Labeler - Blistex Inc (005126354)

Registrant - Accupac LLC (071609663)

Establishment
Name	Address	ID/FEI	Business Operations
Blistex Inc		005126354	manufacture(10157-2119)

Revised: 1/2026

Document Id: 486e2c85-fc94-2304-e063-6294a90a0ea1

34390-5

Set id: 1f2ecc13-fddd-e34b-e063-6294a90a6c54

Version: 2

Effective Time: 20260115